Metabotyping and its application in targeted nutrition: An overview

British Journal of Nutrition

Volumn 117, Issue 12, 2017, Pages 1631-1644

  Riedl, Anna ^a,b   Gieger, Christian ^a,b   Hauner, Hans ^c,d,e   Daniel, Hannelore ^d   Linseisen, Jakob ^a,b,d,f  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f KLINIKUM AUGSBURG   (Germany)

Author keywords

enable Cluster; Metabolic phenotypes; Metabotypes; Metabotyping; Targeted nutrition

Indexed keywords

CAROTENOID; FATTY ACID; LIPOPROTEIN;

ANTHROPOMETRY; ARTICLE; CHRONIC DISEASE; DIASTOLIC BLOOD PRESSURE; EPIGENETICS; HUMAN; INTERVENTION STUDY; METABOLIC DISORDER; METABOLOME; METABOLOMICS; METABOTYPING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL REQUIREMENT; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; DIET THERAPY; NUTRITION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

HUMANS; METABOLIC DISEASES; METABOLOMICS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85024478153     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114517001611     Document Type: Article

References (83)

1. Nicholson JK (2006) Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol 2, 52.
2. Beger RD, Dunn W, Schmidt MA, et al. (2016) Metabolomics enables precision medicine: 'A White Paper, Community Perspective'. Metabolomics 12, 149.
3. de Roos B (2013) Personalised nutrition: ready for practice? Proc Nutr Soc 72, 48-52.
4. Nicholson JK & Holmes E (2006) Global systems biology and personalized healthcare solutions. Discov Med 6, 63-70.
5. Holmes E, Wilson ID & Nicholson JK (2008) Metabolic phenotyping in health and disease. Cell 134, 714-717.
6. O'Donovan CB, Walsh MC, Gibney MJ, et al. (2016) Can metabotyping help deliver the promise of personalised nutrition? Proc Nutr Soc 75, 106-114.
7. Celis-Morales C, Livingstone KM, Marsaux CF, et al. (2017) Effect of personalized nutrition on health-related behaviour change: evidence from the Food4me European randomized controlled trial. Int J Epidemiol 46, 578-588.
8. Livingstone KM, Celis-Morales C, Navas-Carretero S, et al. (2016) Effect of an Internet-based, personalized nutrition randomized trial on dietary changes associated with the Mediterranean diet: the Food4Me Study. Am J Clin Nutr 104, 288-297.
9. Morris C, O'Grada C, Ryan M, et al. (2013) Identification of differential responses to an oral glucose tolerance test in healthy adults. PLOS ONE 8, e72890.
10. Nicholson JK, Holmes E, Kinross JM, et al. (2012) Metabolic phenotyping in clinical and surgical environments. Nature 491, 384-392.
11. Kaput J (2008) Nutrigenomics research for personalized nutrition and medicine. Curr Opin Biotechnol 19, 110-120.
12. Brennan L (2008) Session 2: personalised nutrition. Metabo-lomic applications in nutritional research. Proc Nutr Soc 67, 404-408.
13. Brennan L (2016) Use of metabotyping for optimal nutrition. Curr Opin Biotechnol 44, 35-38.
14. Pontoizeau C, Fearnside JF, Navratil V, et al. (2011) Broad-ranging natural metabotype variation drives physiological plasticity in healthy control inbred rat strains. J Proteome Res 10, 1675-1689.
15. Gavaghan CL, Holmes E, Lenz E, et al. (2000) An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett 484, 169-174.
16. Clayton TA, Lindon JC, Cloarec O, et al. (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440, 1073-1077.
17. Holmes E, Nicholls AW, Lindon JC, et al. (2000) Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem Res Toxicol 13, 471-478.
18. Gavaghan CL, Wilson ID & Nicholson JK (2002) Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett 530, 191-196.
19. Gavaghan McKee CL, Wilson ID & Nicholson JK (2006) Metabolic phenotyping of nude and normal (Alpk:ApfCD, C57BL10J) mice. JProteome Res 5, 378-384.
20. Fearnside JF, Dumas ME, Rothwell AR, et al. (2008) Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice. PLoS ONE 3, e1668.
21. Bollard ME, Holmes E, Lindon JC, et al. (2001) Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. Anal Biochem 295, 194-202.
22. Calvani R, Brasili E, Praticò G, et al. (2014) Fecal and urinary NMR-based metabolomics unveil an aging signature in mice. Exp Gerontol 49, 5-11.
23. Garcia-Perez I, Villasenor A, Wijeyesekera A, et al. (2012) Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model. J Proteome Res 11, 4425-4435.
24. Qiao Q, Li T, Sun J, et al. (2011) Metabolomic analysis of normal (C57BL/6J, 129S1/SvImJ) mice by gas chromatography-mass spectrometry: detection of strain and gender differences. Talanta 85, 718-724.
25. Plumb R, Granger J, Stumpf C, et al. (2003) Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): detection of strain, diurnal and gender differences. Analyst 128, 819-823.
26. Yang Y, Liu Y, Zheng L, et al. (2014) Serum metabonomic analysis of apoE(-/-) mice reveals progression axes for atherosclerosis based on NMR spectroscopy. Mol Biosyst 10, 3170-3178.
27. JPT Higgins & Green S (editors) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. http://handbook.cochrane.org/(accessed November 2016).
28. World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseases. Joint WHO/FAO Expert Consultation. WHO Technical Report Series, no. 916. Geneva: WHO.
29. van Bochove K, van Schalkwijk DB, Parnell LD, et al. (2012) Clustering by plasma lipoprotein profile reveals two distinct subgroups with positive lipid response to fenofibrate therapy. PLOS ONE 7, e38072.
30. O'Sullivan A, Gibney MJ, Connor AO, et al. (2011) Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. Mol Nutr Food Res 55, 679-690.
31. O'Donovan CB, Walsh MC, Nugent AP, et al. (2015) Use of metabotyping for the delivery of personalised nutrition. Mol Nutr Food Res 59, 377-385.
32. Vázquez-Fresno R, Llorach R, Perera A, et al. (2016) Clinical phenotype clustering in cardiovascular risk patients for the identification of responsive metabotypes after red wine polyphenol intake. J Nutr Biochem 28, 114-120.
33. Frazier-Wood AC, Glasser S, Garvey WT, et al. (2011) A clustering analysis of lipoprotein diameters in the metabolic syndrome. Lipids Health Dis 10, 237.
34. Zubair N, Kuzawa CW, McDade TW, et al. (2012) Cluster analysis reveals important determinants of cardiometabolic risk patterns in Filipino women. Asia Pac J Clin Nutr 21, 271-281.
35. Zubair N, Kuzawa CW, Lee NR, et al. (2014) Clustering and determinants of cardiometabolic risk factors among Filipino young adults. Asia Pac J Clin Nutr 23, 148-158.
36. Wilcox MA, Wyszynski DF, Panhuysen CI, et al. (2003) Empirically derived phenotypic subgroups-qualitative and quantitative trait analyses. BMC Genet 4, Suppl. 1, S15.
37. Wilcox M, Li Q, Sun Y, et al. (2009) Genome-wide association study for empirically derived metabolic phenotypes in the Framingham Heart Study offspring cohort. BMC Proc 3, Suppl. 7, S53.
38. Tzeng CR, Chang YC, Chang YC, et al. (2014) Cluster analysis of cardiovascular and metabolic risk factors in women of reproductive age. Fertil Steril 101, 1404-1410.
39. Li K, Brennan L, McNulty BA, et al. (2016) Plasma fatty acid patterns reflect dietary habits and metabolic health: a cross-sectional study. Mol Nutr Food Res 60, 2043-2052.
40. Bermúdez V, Rojas J, Salazar J, et al. (2015) Sensitivity and specificity improvement in abdominal obesity diagnosis using cluster analysis during waist circumference cut-off point selection. J Diabetes Res 2015, 750265.
41. Micciolo R (1992) Clustering of hemodynamic and metabolic abnormalities and of anthropometric characteristics in men and women, aged 21-60 years. Hum Biol 64, 539-566.
42. Baumgartner RN, Siervogel RM & Roche AF (1989) Clustering of cardiovascular risk factors in association with indices of adiposity and adipose tissue distribution in adults. Am J Hum Biol 1, 43-52.
43. Huang RC, Mori TA, Burke V, et al. (2009) Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents. Diabetes Care 32, 695-701.
44. Andreeva-Gateva PA, Simeonov VD, Georrgieva-Nikolova RT, et al. (2014) Cluster analysis of the components of the metabolic syndrome in subjects with an increased risk for diabetes mellitus type 2. Endocrinologya 19, 168-185.
45. Ventura AK, Loken E & Birch LL (2006) Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls. Pediatrics 118, 2434-2442.
46. Bucci CM, Legnani WE & Armentano RL (2016) Clinical values dataset processing through cluster analysis to find cardiovascular risk. J Phys Conf Ser 705, 012033.
47. Moazzami AA, Shrestha A, Morrison DA, et al. (2014) Metabolomics reveals differences in postprandial responses to breads and fasting metabolic characteristics associated with postprandial insulin demand in postmenopausal women. J Nutr 144, 807-814.
48. Qureshi W, Wagenknecht L, Watkins S, et al. (2014) Abstract 23: metabolomic features associated with incident hypertension-results from Insulin Resistance Atherosclerosis Study. Circulation 129, Suppl. 1, A23.
49. Krishnan S, Newman JW, Hembrooke TA, et al. (2012) Variation in metabolic responses to meal challenges differing in glycemic index in healthy women: Is it meaningful? Nutr Metab (Lond) 9, 26.
50. Wang TT, Edwards AJ & Clevidence BA (2013) Strong and weak plasma response to dietary carotenoids identified by cluster analysis and linked to beta-carotene 15, 15'-mono-oxygenase 1 single nucleotide polymorphisms. J Nutr Biochem 24, 1538-1546.
51. Bouwman J, Vogels JT, Wopereis S, et al. (2012) Visualization and identification of health space, based on personalized molecular phenotype and treatment response to relevant underlying biological processes. BMC Med Genomics 5, 1.
52. Chua EC, Shui G, Lee IT, et al. (2013) Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans. Proc Natl Acad Sci USA 110, 14468-14473.
53. Zák A, Burda M, Vecka M, et al. (2014) Fatty acid composition indicates two types of metabolic syndrome independent of clinical and laboratory parameters. Physiol Res 63, Suppl. 3, S375-S385.
54. Schader LM (2015) Comparison of genetic risk factors between two type II diabetes subtypes. Bachelor Thesis, University of Arizona.
55. Li L, Cheng WY, Glicksberg BS, et al. (2015) Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med 7, 311ra174.
56. Amato MC, Pizzolanti G, Torregrossa V, et al. (2016) Pheno-typing of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: results of a two-step cluster analysis. J Diabetes Investig 7, 219-225.
57. Frei F, Lessa Bde S, Nogueira JC, et al. (2013) Cluster analysis for classification of patients submitted to Fobi-Capella bariatric surgery. Arq Bras Cir Dig 26, Suppl. 1, 33-38.
58. Arguelles W, Llabre MM, Sacco RL, et al. (2015) Characterization of metabolic syndrome among diverse Hispanics/Latinos living in the United States: latent class analysis from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Int J Cardiol 184, 373-379.
59. Kim E, Oh W, Pieczkiewicz DS, et al. (2014) Divisive hierarchical clustering towards identifying clinically significant pre-diabetes subpopulations. AMIA Annu Symp Proc 2014, 1815-1824.
60. Mäkinen VP, Soininen P, Forsblom C, et al. (2008) 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 4, 167.
61. Botelho PB, Fioratti CO, Abdalla DS, et al. (2010) Classification of individuals with dyslipidaemia controlled by statins according to plasma biomarkers of oxidative stress using cluster analysis. Br J Nutr 103, 256-265.
62. Holmes E, Loo RL, Stamler J, et al. (2008) Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453, 396-400.
63. Lenz EM, Bright J, Wilson ID, et al. (2004) Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J Pharm Biomed Anal 36, 841-849.
64. Dumas ME, Maibaum EC, Teague C, et al. (2006) Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. Anal Chem 78, 2199-2208.
65. Chaleckis R, Murakami I, Takada J, et al. (2016) Individual variability in human blood metabolites identifies age-related differences. Proc Natl Acad Sci USA 113, 4252-4259.
66. Bernini P, Bertini I, Luchinat C, et al. (2009) Individual human phenotypes in metabolic space and time. J Proteome Res 8, 4264-4271.
67. Yousri NA, Kastenmüller G, Gieger C, et al. (2014) Long term conservation of human metabolic phenotypes and link to heritability. Metabolomics 10, 1005-1017.
68. Krumsiek J, Mittelstrass K, Do KT, et al. (2015) Gender-specific pathway differences in the human serum metabo-lome. Metabolomics 11, 1815-1833.
69. Kochhar S, Jacobs DM, Ramadan Z, et al. (2006) Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Anal Biochem 352, 274-281.
70. Bartel J, Krumsiek J & Theis FJ (2013) Statistical methods for the analysis of high-throughput metabolomics data. Comput Struct Biotechnol J 4, e201301009.
71. Valdes AM, Glass D & Spector TD (2013) Omics technologies and the study of human ageing. Nat Rev Genet 14, 601-607.
72. Kurland IJ, Accili D, Burant C, et al. (2013) Application of combined omics platforms to accelerate biomedical discovery in diabesity. Ann N Y Acad Sci 1287, 1-16.
73. Krug S, Kastenmüller G, Stückler F, et al. (2012) The dynamic range of the human metabolome revealed by challenges. FASEB J 26, 2607-2619.
74. Rezzi S, Martin FP, Alonso C, et al. (2009) Metabotyping of biofluids reveals stress-based differences in gut permeability in healthy individuals. J Proteome Res 8, 4799-4809.
75. Ghini V, Saccenti E, Tenori L, et al. (2015) Allostasis and resilience of the human individual metabolic phenotype. J Proteome Res 14, 2951-2962.
76. Assfalg M, Bertini I, Colangiuli D, et al. (2008) Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci USA 105, 1420-1424.
77. Jain AK, Duin RPW & Mao J (2000) Statistical pattern recognition: a review. IEEE Trans Pattern Anal Mach Intell 22, 4-37.
78. Everitt BS, Landau S, Leese M, et al. (2011) Measurement of proximity. In Cluster Analysis, 5th ed., pp. 67-68 [DJ Balding, NAC Cressie, GM Fitzmaurice, et al., editors]. London: John Wiley & Sons, Ltd.
79. Kaufman L & Rousseeuw PJ (2005) Finding Groups in Data: An Introduction to Cluster Analysis. Hoboken: John Wiley & Sons, Inc.
80. Jain AK, Topchy A, Law MHC, et al. (2004) Landscape of clustering algorithms. Proceedings of the 17th International Conference on Pattern Recognition (ICPR'04), Vol. 1, pp. 260-263.
81. Steinley D (2006) K-means clustering: a half-century synthesis. Br J Math Stat Psychol 59, 1-34.
82. Bacher J, Pöge A & Wenzig K (2010) Clusteranalyse-Anwen-dungsorientierte Einführung in Klassifikationsverfahren (Cluster Analysis-Application-Oriented Introduction to Classification Methods), 3rd ed. Munich: Oldenbourg Wissenschaftsverlag GmbH.
83. Dua S & Chowriappa P (2013) Data Mining for Bioinfor-matics. Boca Raton, FL: CRC Press Taylor & Francis Group.